Welcome subscribers,
This week, we examine how Europe's research facilities are pioneering ESG solutions, with six leading examples proving labs can achieve sustainability without sacrificing science. You will also find our usual roundup of deals: leases, acquisitions and developments.
✅ Finland: healthcare in Helsinki
✅ Germany: LAB 1 in Mainz
🔒 Spain: QIAGEN's new hub in Barcelona
🔒 UK: British Land gets approval in Oxford
(🔒 for paying members only)
Read below for full details.
— Stephen Ryan (connect with me on LinkedIn)
🔍 Need deeper insights into life sciences real estate?
In addition to our regular updates, we offer bespoke research and strategic analysis for investors and developers in the life sciences sector. Whether you’re evaluating an acquisition, tracking market trends, or need a custom report, our team can help you make informed decisions.
Get in touch to discuss how we can support your next project.
How ESG is transforming European lab design
Europe's energy-intensive labs are pioneering ESG solutions, from London's intelligent building systems to Copenhagen's low-carbon retrofits.
Transactions
FINLAND HELSINKI
PPI acquired two healthcare properties in Helsinki's Tikkurila district for €63 million (£53 million) total property value. The properties, constructed in 2019 and 2021, offer a combined lettable area of approximately 13,520 sq m. One property is a hospital providing specialist health services, fully leased to Mehiläinen on a 12-year remaining lease. The second is a multi-tenant building with tenants including City of Vantaa, Forenom, Nordea, Terveystalo and Kesko. Both properties offer direct access to Tikkurila train station, Finland's third busiest.
GERMANY DÜSSELDORF
YORCKS Düsseldorf is 75 per cent pre-leased before completion, with the Volkshochschule Düsseldorf securing 16,000 sq m of the total 28,600 sq m. US biotechnology company Bio-Techne has leased 1,120 sq m for over ten years. The first phase completes mid-2026.
Would you like instant access to 1,000+ deals like these? Our data tool lets you filter, sort and search European life sciences transactions spanning 24 countries—whether you're tracking a single city or spotting market patterns others miss.
GERMANY MAINZ
TRON (Translational Oncology Mainz) will occupy approximately 1,032 sq m of the 3,000 sq m LAB 1 building from September 2025. Around 40 employees from four functional units will relocate from Freiligrathstraße to access new laboratories for cell cultivation, cloning and microscopy. TRON is constructing a new research and administration building near the university medical centre, expected to complete in 2027. The InnovationLabz development also includes Lifecare and LigniLabs as tenants.
